Australia's Therapeutic Goods Administration has new structural arrangements, first change in 20 years
The Australian Therapeutic Goods Administration (TGA) will officially launch a new organizational structure on 1 July 1, 2010, aimed at supporting the regulatory agency's delivery of appropriate, consistent, effective and efficient regulation into the future.
This is the first time the TGA has comprehensively reviewed and implemented changes to the organization of its services since it was established in 1989, ie, nearly 20 years. Over this time the TGA says it has developed a robust regulatory framework, well-suited to the products regulated. However, in the face of rapid industry evolution, the TGA, along with most international regulators, must adapt to meet the challenges of the 21st Century.
The TGA's offices will be arranged in three groups, based on their area of regulatory oversight:
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
More Features in Pharmaceutical
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze